Fama v. P & M SorbaraFama v. P & M Sorbara
APPEARANCES OF COUNSEL
Steven Licht, Special Funds Conservation Committee, Albany (Melissa A. Day of counsel), for appellant.
Douglas J. Hayden, State Insurance Fund, White Plains (Patricia M. Barry of counsel), for P & M Sorbara and another, respondents.
OPINION OF THE COURT
Cardona, P.J.
Under the
The instant case—in addition to two companion cases before us (see Matter of Dallas v Consolidated Edison, 27 AD3d 907 [2006]; Matter of Cecere v Consolidated Edison, 27 AD3d 932 [2006])—is emblematic of the high number of asbestos cases where application of the foregoing principles is complicated by the fact that the disabled worker is simultaneously afflicted with a dust disease, such as asbestosis, as well as a nondust disease, like asbestos-related pleural disease (hereinafter ARPD).1 Claimant herein, a concrete worker for 37 years, was exposed to asbestos repeatedly during his career, with his last such exposure occurring in the mid-1990s while working for P & M Sorbara (hereinafter the employer). He was diagnosed with asbestosis and ARPD in 1999 and, following his claim for workers’ compensation benefits, an independent medical examination essentially confirmed that diagnosis.2 The Workers’ Compensation Board ultimately established the claim for asbestosis, but noted parenthetically that claimant had submitted prima facie medical evidence of a claim for ARPD.
On this appeal, the Special Funds Conservation Committee argues that the Board erred in failing to establish one claim for claimant‘s asbestosis, pursuant to
Initially, addressing the threshold claim that the Board‘s determination was not supported by substantial evidence, “[i]t is well settled that ‘[t]he determination of the medical condition
Moreover, we decline the Special Funds’ request to mandate that the Board generally require separate claims for dust diseases and nondust diseases. On the contrary, we view the Board‘s treatment of hybrid claims such as claimant‘s to be entirely rational in light of the law and the available medical opinions concerning asbestos-related lung diseases. The Board has consistently held that, where a claimant suffers from both a dust disease and a nondust disease and his or her disability is attributable, at least in part, to the dust disease, the provisions of the
The Board‘s treatment of hybrid cases is also consistent with the medical opinions in this and other cases. As the Board has repeatedly observed, dust diseases are typically more serious than nondust diseases and usually contribute to the claimant‘s disability to a greater extent (see e.g. Schiavone Shea Joint Venture, supra). Moreover, it appears to be exceedingly difficult to ratably apportion a claimant‘s disability between a dust disease and a nondust disease inasmuch as each disorder affects the lungs and arises from the same occupational exposure to asbestos (see id.). Therefore, for the foregoing reasons, we hold that where there is medical evidence that the claimant‘s disability is due, at least in part, to the existence of a dust disease, a separate claim is not necessary for a nondust disease arising from workplace asbestos exposure. Instead, in such cases, the dust disease diagnosis should take precedence and the claim should be established under
Spain, Carpinello, Mugglin and Lahtinen, JJ., concur.
Ordered that the decision is affirmed, without costs.